BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34351450)

  • 1. Postsurgical geometrical variations of tumor bed and brainstem during photon and proton therapy for pediatric tumors of the posterior fossa: dosimetric impact and predictive factors.
    Volpe S; Bondiau PY; Claude L; Claren A; Padovani L; AlGhamdi H; Duhil De Benaze G; Opitz L; Baudin G; Dejean C; Maneval D; Jereczek-Fossa BA; Doyen J
    Strahlenther Onkol; 2021 Dec; 197(12):1113-1123. PubMed ID: 34351450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brainstem Injury in Pediatric Patients Receiving Posterior Fossa Photon Radiation.
    Devine CA; Liu KX; Ioakeim-Ioannidou M; Susko M; Poussaint TY; Huisman TAGM; Aboian M; Brown D; Zaslowe-Dude C; Rao AD; Orlina LT; Rawal B; Mueller S; Marcus KJ; Terezakis SA; Braunstein SE; Haas-Kogan DA
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1034-1042. PubMed ID: 31472183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brainstem Injury in Pediatric Patients With Posterior Fossa Tumors Treated With Proton Beam Therapy and Associated Dosimetric Factors.
    Gentile MS; Yeap BY; Paganetti H; Goebel CP; Gaudet DE; Gallotto SL; Weyman EA; Morgan ML; MacDonald SM; Giantsoudi D; Adams J; Tarbell NJ; Kooy H; Yock TI
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):719-729. PubMed ID: 29413284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury.
    Haas-Kogan D; Indelicato D; Paganetti H; Esiashvili N; Mahajan A; Yock T; Flampouri S; MacDonald S; Fouladi M; Stephen K; Kalapurakal J; Terezakis S; Kooy H; Grosshans D; Makrigiorgos M; Mishra K; Poussaint TY; Cohen K; Fitzgerald T; Gondi V; Liu A; Michalski J; Mirkovic D; Mohan R; Perkins S; Wong K; Vikram B; Buchsbaum J; Kun L
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):152-168. PubMed ID: 29619963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Acute and Late Brainstem Toxicities With Dose-Volume Data for Pediatric Patients With Posterior Fossa Malignancies.
    Nanda RH; Ganju RG; Schreibmann E; Chen Z; Zhang C; Jegadeesh N; Cassidy R; Deng C; Eaton BR; Esiashvili N
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):360-366. PubMed ID: 28463155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for Linear Energy Transfer and Dose-Volume Parameters for the Brainstem and Organs at Risk.
    Giantsoudi D; Adams J; MacDonald SM; Paganetti H
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):401-410. PubMed ID: 27986346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy.
    Indelicato DJ; Flampouri S; Rotondo RL; Bradley JA; Morris CG; Aldana PR; Sandler E; Mendenhall NP
    Acta Oncol; 2014 Oct; 53(10):1298-304. PubMed ID: 25279957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma.
    Chau RM; Teo PM; Choi PH; Cheung KY; Lee WY
    Radiother Oncol; 2001 Feb; 58(2):143-53. PubMed ID: 11166865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The local field in infratentorial ependymoma: does the entire posterior fossa need to be treated?
    Paulino AC
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):757-61. PubMed ID: 11172959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformal proton radiation therapy of the posterior fossa: a study comparing protons with three-dimensional planned photons in limiting dose to auditory structures.
    Lin R; Hug EB; Schaefer RA; Miller DW; Slater JM; Slater JD
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1219-26. PubMed ID: 11072181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity-modulated arc therapy for pediatric posterior fossa tumors.
    Beltran C; Gray J; Merchant TE
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e299-304. PubMed ID: 21570213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic organ motion and dosimetric implications during horizontal patient rotation for prostate radiation therapy.
    Buckley JG; Dowling JA; Sidhom M; Liney GP; Rai R; Metcalfe PE; Holloway LC; Keall PJ
    Med Phys; 2021 Jan; 48(1):397-413. PubMed ID: 33151543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of positron emission tomography on primary tumour delineation and dosimetric outcome in intensity modulated radiotherapy of early T-stage nasopharyngeal carcinoma.
    Wu VW; Leung WS; Wong KL; Chan YK; Law WL; Leung WK; Yu YL
    Radiat Oncol; 2016 Aug; 11(1):109. PubMed ID: 27558690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly Conformal Craniospinal Radiotherapy Techniques Can Underdose the Cranial Clinical Target Volume if Leptomeningeal Extension through Skull Base Exit Foramina is not Contoured.
    Noble DJ; Ajithkumar T; Lambert J; Gleeson I; Williams MV; Jefferies SJ
    Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):439-447. PubMed ID: 28318880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time 4DMRI-based internal target volume definition for moving lung tumors.
    Rabe M; Thieke C; Düsberg M; Neppl S; Gerum S; Reiner M; Nicolay NH; Schlemmer HP; Debus J; Dinkel J; Landry G; Parodi K; Belka C; Kurz C; Kamp F
    Med Phys; 2020 Apr; 47(4):1431-1442. PubMed ID: 31955430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the benefits and risks of proton therapy in pediatric craniopharyngioma.
    Beltran C; Roca M; Merchant TE
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e281-7. PubMed ID: 21570209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic conformal radiotherapy for posterior fossa tumours: a modelling study for potential improvement in therapeutic ratio.
    Murthy V; Jalali R; Sarin R; Nehru RM; Deshpande D; Dinshaw KA
    Radiother Oncol; 2003 May; 67(2):191-8. PubMed ID: 12812850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of CNS Injury for a Cohort of 111 Patients Treated With Proton Therapy for Medulloblastoma: LET and RBE Associations for Areas of Injury.
    Giantsoudi D; Sethi RV; Yeap BY; Eaton BR; Ebb DH; Caruso PA; Rapalino O; Chen YE; Adams JA; Yock TI; Tarbell NJ; Paganetti H; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):287-296. PubMed ID: 26691786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.